Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

13.9%

95 terminated/withdrawn out of 685 trials

Success Rate

83.0%

-3.5% vs industry average

Late-Stage Pipeline

9%

64 trials in Phase 3/4

Results Transparency

61%

284 of 465 completed trials have results

Key Signals

39 recruiting284 with results71 terminated24 withdrawn

Enrollment Performance

Analytics

N/A
349(81.2%)
Phase 4
45(10.5%)
Phase 3
19(4.4%)
Phase 1
8(1.9%)
Phase 2
8(1.9%)
Early Phase 1
1(0.2%)
430Total
N/A(349)
Phase 4(45)
Phase 3(19)
Phase 1(8)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (685)

Showing 20 of 685 trials
NCT06885177Not ApplicableActive Not Recruiting

TECTONIC CAD IVL IDE Study

Role: lead

NCT03433274Not ApplicableActive Not Recruiting

Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Role: lead

NCT04011722Not ApplicableActive Not Recruiting

Portico Next Generation Approval Study

Role: lead

NCT07287423Not ApplicableRecruiting

LEAP 2 Chronic EFS

Role: lead

NCT05027984Not ApplicableActive Not Recruiting

Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS

Role: collaborator

NCT07523620Not ApplicableRecruiting

Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration

Role: lead

NCT05072730Not ApplicableCompleted

ComparIson of Strategies to PrepAre SeveRely CALCified Coronary Lesions 2

Role: collaborator

NCT07696182Not ApplicableNot Yet Recruiting

Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR

Role: lead

NCT06008080Recruiting

Post-Market Clinical Follow Up Study With Navitor Valve

Role: lead

NCT06590467Recruiting

Abbott Structural Heart Device Registry

Role: lead

NCT06306573Enrolling By Invitation

CardioMEMS HF System Real-World Evidence Post-Approval Study

Role: lead

NCT06436053Recruiting

Acute Response to Left Bundle Branch Area Pacing With SyncAV

Role: lead

NCT05061004Not ApplicableRecruiting

Cephea Early Feasibility Study

Role: lead

NCT06189365Terminated

Amplatzer Amulet China Post Market Study (PMS)

Role: lead

NCT07586995Recruiting

A Post-Market Assessment of the Safety and Performance of the TriClip™ System

Role: lead

NCT05491200Phase 4Recruiting

Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients

Role: collaborator

NCT07421076Not ApplicableRecruiting

Grid eXplore Mapping Study

Role: lead

NCT06423430Not ApplicableRecruiting

Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)

Role: lead

NCT03667196Recruiting

Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions

Role: collaborator

NCT07069673Recruiting

Abbott Cephea Mitral Valve Disease Registry

Role: lead